Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE7A | Q13946 | 16/20 | 0.47 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.43 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL551553 | 0.97 | PDE7A (0.50) | PDE7ACRBNPDE7B | |
| SCHEMBL11491220 | 0.97 | PDE7A (0.50) | PDE7ACRBNPDE7B | |
| SCHEMBL351324 | 0.97 | PDE7A (0.50) | PDE7ACRBNPDE7B | |
| SCHEMBL11870539 | 0.97 | PDE7A (0.50) | PDE7ACRBNPDE7B | |
| SCHEMBL22422289 | 0.97 | PDE7A (0.50) | PDE7ACRBNPDE7B | |
| SCHEMBL630549 | 0.95 | CRBN (0.43) | PDE7ACRBNPDE7B | |
| SCHEMBL8775591 | 0.89 | — | — | |
| SCHEMBL23039345 | 0.84 | PDE7A (0.41) | PDE7ACRBNPDE7B | |
| SCHEMBL31721361 | 0.83 | CRBN (0.40) | PDE7ACRBN | |
| SCHEMBL23651601 | 0.83 | PDE7A (0.38) | PDE7ACRBNPDE7B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8822516-B2 | Process for the preparation of iodides | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2014-09-02 | — | — | US | claimed |
| US-20130165658-A1 | PROCESS FOR THE PREPARATION OF IODIDES | TECHNION R&D FOUNDATION LTD. (IL) | 2013-06-27 | — | — | US | claimed |
| WO-2011154953-A1 | PROCESS FOR THE PREPARATION OF IODIDES | TECHNION R&D FOUNDATION LTD. (IL) | 2011-12-15 | — | — | WO | claimed |
| EP-1042315-B1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE CO CHEM PHARM FAB (DE) | 2004-04-14 | — | — | EP | claimed |
| EP-1042315-A1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | Klinge Pharma GmbH (DE) | 2000-10-11 | — | — | EP | claimed |
| WO-1999031087-A1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE PHARMA GMBH (DE) | 1999-06-24 | — | — | WO | claimed |
| US-5338859-A | Reacting a hydantoin with a calcium base; crystallization; precipitation; separation | HOECHST CELANESE CORPORATION (US) | 1994-08-16 | — | — | US | claimed |
| US-4436910-A | SAPONIFICATION | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1984-03-13 | — | — | US | claimed |
| US-4320135-A | HORMONE INHIBITORS, ANTIDIABETIC AGENTS, TREATMENT OF MICROANGIOPATHY | SANDOZ, INC. (US) | 1982-03-16 | — | — | US | claimed |
| US-12637433-B2 | Histone deacetylase inhibitors | THE UNIVERSITY OF QUEENSLAND (AU) | 2026-05-26 | — | — | US | disclosed |
| WO-2025230799-A2 | CYCLOALKYL- AND PIPERIDINYL-CONTAINING DIAMINOMETHYLENE PYRIMIDINE-2,4,6-TRIONE AGONISTS OF PARATHYROID HORMONE 1 AND INCRETIN RECEPTORS | SEPTERNA, INC. (US) | 2025-11-06 | — | — | WO | disclosed |
| EP-3947365-B1 | SUBSTITUTED-N-HETEROARYL COMPOUNDS AND USES THEREOF | BIONOMICS LTD (AU) | 2025-10-01 | — | — | EP | disclosed |
| EP-4613731-A1 | HALOETHER, METHOD FOR PRODUCING SAME, VINYL ETHER, AND METHOD FOR PRODUCING SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2025-09-10 | — | — | EP | disclosed |
| US-20250228865-A1 | COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME | SANOFI US SERVICES INC. (US) | 2025-07-17 | — | — | US | disclosed |
| US-4227005-A | (B-HYDROXYETHYL)-5,5-DIMETHYLHYDANTOIN | CIBA-GEIGY AG (CH) | 1980-10-07 | — | — | US | disclosed |
| US-4189587-A | CORROSION RESISTANCE | CIBA-GEIGY CORPORATION (US) | 1980-02-19 | — | — | US | disclosed |
| US-4161594-A | DERIVATIVES OF BARBITURIC ACID, HYDANTOIN, AND DIHYDROURACIL, POLYMER INTERMEDIATES | CIBA-GEIGY AG (CH) | 1979-07-17 | — | — | US | disclosed |
| US-4060525-A | DIGLYCIDYL COMPOUND INTERMEDIATES | CIBA-GEIGY AG (CH) | 1977-11-29 | — | — | US | disclosed |
| US-3975397-A | STORAGE STORAGE STABLE, DIMENSIONAL STABILITY, MECHANICAL STRENGTH | CIBA-GEIGY CORPORATION (US) | 1976-08-17 | — | — | US | disclosed |
| US-3948916-A | HYDANTOINS OR URACILS, POLYEPOXIDES | CIBA-GEIGY AG (CH) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637433-B2 | Histone deacetylase inhibitors | HDAC1, HDAC11, HDAC3 | PDE7A 555/4885CRBN 3060/4885PDE7B 1630/4885 |
| US-20250228865-A1 | COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME | UPF1, NUDT21, RNGTT | PDE7A 2037/4885CRBN 1442/4885PDE7B 1210/4885 |
| US-20130165658-A1 | PROCESS FOR THE PREPARATION OF IODIDES | NISCH, TPO, HDHD5 | PDE7A 1691/4885CRBN 1229/4885PDE7B 3219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.